Business Context and Reporting Period
Company: Omeros Corporation
Filing Type: Form 8-K (Current Report)
Date of Report: March 18, 2013
Reporting Period: The filing announces financial results for the three months and the full year ended December 31, 2012.
Key Financial Metrics
The provided text is a cover report referencing a press release (Exhibit 99.1) for detailed financial data. The filing text itself does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity.
Material Changes
The filing text does not contain specific comparative data or details regarding material changes versus prior periods. It solely serves to incorporate the press release by reference.
Guidance, Outlook, and Risks
Management Commentary: The report states that a press release was issued on March 18, 2013, containing the financial results. No specific guidance, outlook, or risk factors are detailed within the body of this 8-K text.
Legal Disclaimer: The information in this report and the accompanying exhibit is not deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934 and shall not be incorporated by reference into any other SEC filings.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release dated March 18, 2013) for actual revenue, net loss, and cash position figures.
- Verify the specific financial results for the quarter and year ended December 31, 2012, as they are not listed in the 8-K summary text.
- Check for any forward-looking statements or clinical trial updates contained within the referenced press release.